Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900025705Phase 4Recruiting
Phase 4, randomised, double-blind trial of butorphanol in anesthesia-related complication (3 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Emergence agitation. Started Aug 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900025705.